Illumina, Inc. (ILMN)
218.22
-3.44
(-1.55%)
USD |
NASDAQ |
Sep 04, 16:00
220.27
+2.05
(+0.94%)
After-Hours: 04:59
Illumina Enterprise Value : 34.31B for Sept. 4, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 04, 2026 | 34.31B |
| September 03, 2026 | 34.83B |
| September 02, 2026 | 33.56B |
| September 01, 2026 | 32.64B |
| August 31, 2026 | 33.62B |
| August 28, 2026 | 33.91B |
| August 27, 2026 | 35.74B |
| August 26, 2026 | 35.31B |
| August 25, 2026 | 35.33B |
| August 24, 2026 | 35.07B |
| August 21, 2026 | 34.49B |
| August 20, 2026 | 33.56B |
| August 19, 2026 | 32.31B |
| August 18, 2026 | 29.79B |
| August 17, 2026 | 30.52B |
| August 14, 2026 | 30.18B |
| August 13, 2026 | 30.45B |
| August 12, 2026 | 30.49B |
| August 11, 2026 | 30.48B |
| August 10, 2026 | 30.32B |
| August 07, 2026 | 29.74B |
| August 06, 2026 | 30.61B |
| August 05, 2026 | 31.54B |
| August 04, 2026 | 32.01B |
| August 03, 2026 | 31.28B |
| Date | Value |
|---|---|
| July 31, 2026 | 32.33B |
| July 30, 2026 | 32.33B |
| July 29, 2026 | 30.78B |
| July 28, 2026 | 30.50B |
| July 27, 2026 | 29.97B |
| July 24, 2026 | 30.67B |
| July 23, 2026 | 31.08B |
| July 22, 2026 | 30.18B |
| July 21, 2026 | 30.43B |
| July 20, 2026 | 29.25B |
| July 17, 2026 | 29.54B |
| July 16, 2026 | 30.09B |
| July 15, 2026 | 29.62B |
| July 14, 2026 | 30.23B |
| July 13, 2026 | 30.06B |
| July 10, 2026 | 30.08B |
| July 09, 2026 | 30.62B |
| July 08, 2026 | 29.72B |
| July 07, 2026 | 30.31B |
| July 06, 2026 | 30.70B |
| July 02, 2026 | 29.85B |
| July 01, 2026 | 29.13B |
| June 30, 2026 | 27.91B |
| June 29, 2026 | 28.92B |
| June 26, 2026 | 28.22B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Thermo Fisher Scientific, Inc. | 265.55B |
| Agilent Technologies, Inc. | 44.73B |
| Danaher Corp. | 169.49B |
| Pacific Biosciences of California, Inc. | 888.81M |
| Bio-Rad Laboratories, Inc. | 10.07B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 207.00M |
| Revenue (Quarterly) | 1.161B |
| Total Expenses (Quarterly) | 954.00M |
| EPS Diluted (Quarterly) | 1.353 |
| Gross Profit Margin (Quarterly) | 66.49% |
| Profit Margin (Quarterly) | 17.83% |
| Earnings Yield | 2.46% |
| Operating Earnings Yield | 2.66% |
| Normalized Earnings Yield | 2.150 |